This finding is further supported by in silico survival analysis of GC patients using publicly available datasets, which revealed a strong association between elevated MCAM expression and poor survival outcomes, consistently observed across two platforms, KM plotter and GEPIA (Fig. 1E). Here, MCAM is linked to gastric cancer.